PEMBROLIZUMAB vs TORIPALIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
PEMBROLIZUMAB vs TORIPALIMAB: Safety Overview
| Metric | PEMBROLIZUMAB | TORIPALIMAB |
|---|---|---|
| Total FAERS Reports | 83,779 | 1,344 |
| Deaths Reported | 15,543 | 65 |
| Death Rate | 18.6% | 4.8% |
| Hospitalizations | 35,472 | 823 |
| Average Patient Age | 64.1 yrs | 58.0 yrs |
| % Female Patients | 49.9% | 24.9% |
| Manufacturer | Merck Sharp & Dohme LLC | Coherus Oncology, Inc. |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | Prescription | N/A |